Can statins lower Lp(a)?

No, statins do not lower Lp(a). In fact, statins can sometimes raise Lp(a) slightly. They are still protective in patients with high Lp(a) because they lower ApoB and overall plaque burden.

Is niacin good for Lp(a)?

Niacin lowers Lp(a) by about 20 to 30%, but large outcome trials showed it did not reduce heart attacks. It also has notable side effects like flushing and liver issues, so we rarely use it now.

Are there new treatments coming for Lp(a)?

Yes, gene-silencing therapies (antisense oligonucleotides like pelacarsen and small interfering RNAs like olpasiran) that quiet the LPA gene in the liver are in phase 3 trials. We are watching them closely. Until they are approved, focused lipid management is the standard.

Should children be tested for Lp(a)?

Children should be tested for Lp(a) when there is a strong family history of early heart disease or a known parental high level. Cascade testing of children of high-Lp(a) parents lets us start prevention well before adulthood.

What units are used to report Lp(a)?

Lp(a) is reported in either mg/dL (mass) or nmol/L (particle count). The nmol/L unit is preferred because it does not depend on particle size. Common thresholds are 30 mg/dL or 75 nmol/L for elevated, and 50 mg/dL or 125 nmol/L for high.

Do I need a CT Coronary Angiogram if my Lp(a) is high?

Yes, a CT Coronary Angiogram (CTA) is often appropriate if your Lp(a) is high, especially after age 40 or with family history. It shows soft and calcified plaque so we can match treatment intensity to the actual disease.

Does exercise lower Lp(a)?

Exercise does not lower Lp(a) meaningfully. Exercise still helps the heart through other paths, including lower ApoB, better insulin sensitivity, and lower blood pressure. People with high Lp(a) need exercise plus medical strategy.

How does Lp(a) interact with menopause?

Lp(a) can rise modestly after menopause because of changing hormone levels. We retest once after menopause to confirm a new baseline. Hormone therapy choices may also be informed by your Lp(a) level.

How does Lp(a) drive plaque differently than LDL?

Lp(a) drives plaque differently than LDL because it carries an extra protein, apolipoprotein(a), that resembles plasminogen, a clot-dissolving protein. This molecular mimicry slows clot dissolution and adds clotting risk on top of the cholesterol-driven plaque buildup that LDL alone causes.

What is the connection between Lp(a) and aortic stenosis?

The connection between Lp(a) and aortic stenosis is direct. Lp(a) deposits in the aortic valve leaflets, where it triggers inflammation and calcium deposition over years. The valve thickens and narrows. People with very high Lp(a) have higher rates of severe aortic stenosis at younger ages.

What is the difference between pelacarsen and olpasiran?

The difference between pelacarsen and olpasiran is the type of RNA-based silencer. Pelacarsen is an antisense oligonucleotide (ASO), which is a short genetic snippet. Olpasiran is small interfering RNA (siRNA). Both target the LPA gene in the liver to lower Lp(a) production.

How often should I retest Lp(a)?

You should retest Lp(a) once after the first measurement to confirm the value, especially if pregnancy, kidney disease, or thyroid issues might have skewed the first result. After confirmation, retesting is rarely needed unless a new specific Lp(a) drug becomes part of your plan.

Why is PCSK9 inhibition useful in high Lp(a)?

PCSK9 inhibition is useful in high Lp(a) because it lowers both ApoB and Lp(a) at the same time. PCSK9 inhibitors raise the number of LDL receptors on liver cells, which clear LDL and some Lp(a) particles. They are often covered by insurance for high-risk patients.

Can lipoprotein apheresis help?

Lipoprotein apheresis can help in very high risk Lp(a) patients with progressive disease despite medication. It is a dialysis-like procedure that filters Lp(a) and LDL out of the blood. It is uncommon, expensive, and reserved for select cases.

Does Lp(a) increase stroke risk?

Yes, Lp(a) increases stroke risk, especially ischemic stroke (the kind caused by a clot or plaque blocking a brain artery). The same plaque-driving and clotting effects that raise heart attack risk also raise stroke risk in the carotid and cerebral arteries.

How does Lp(a) interact with diabetes?

Lp(a) interacts with diabetes in a complex way. People with very low Lp(a) appear to have a slightly higher risk of type 2 diabetes, while those with high Lp(a) have higher cardiovascular risk. The cardiovascular risk dominates the picture.

Why is family history so important if Lp(a) explains it?

Family history is so important because Lp(a) is a major hidden cause of unexplained early heart attacks. A parent or sibling with a heart event before 55 in men or 65 in women makes Lp(a) much more likely. Testing closes the mystery for the whole family.

What lifestyle changes help most with high Lp(a)?

Lifestyle changes that help most with high Lp(a) target the surrounding risk: not smoking, regular cardio plus strength training, a high-fiber diet, sleep above seven hours, blood pressure under 120/80, and tight glucose control. None of these lower Lp(a) directly. All of them lower the disease it causes.

Is there a link between Lp(a) and inflammation?

Yes, there is a link between Lp(a) and inflammation. Lp(a) carries oxidized phospholipids, which are pro-inflammatory molecules that activate immune cells in the artery wall. That extra inflammation is part of why Lp(a) drives plaque faster than LDL alone.

Why does Fishtown Medicine treat Lp(a) as a one-time priority test?

Fishtown Medicine treats Lp(a) as a one-time priority test because the result reshapes lifelong prevention. A single $40 lab tells us whether to push ApoB to 30 instead of 80, whether to image earlier, and whether to test the rest of the family. Few tests offer that much leverage.

Can statins lower Lp(a)?

No. In fact, statins can sometimes slightly *raise* Lp(a), though they are still protective because they lower the other harmful cholesterol (ApoB).

Is niacin good for this?

Niacin lowers Lp(a) by about 20 to 30%, but large trials showed it did not reduce heart attacks. We rarely use it now due to side effects.

Are there new treatments coming?

Yes. Gene silencing therapies (ASO and siRNA) that shut down Lp(a) production in the liver are in phase 3 trials. We are watching them closely. Until then, focused lipid management is the standard.

TL;DR · 30-second take

Lipoprotein(a), said L-P-little-A, is a genetic cholesterol particle that drives heart attacks and aortic valve narrowing. About 1 in 5 adults carry high levels. It is not on standard cholesterol panels. We test every patient once because the result rarely changes and it shapes lifelong prevention.

Lipoprotein(a): The Genetic Particle Doctors Miss

TL;DR: Lipoprotein(a), or Lp(a), is a genetically determined cholesterol particle that is highly inflammatory and pro-clotting. It causes heart attacks in healthy, fit people who "did everything right." It is not on a standard lipid panel. You must specifically ask for it. At Fishtown Medicine, we test every patient once. If we do not look, we cannot treat.

Imagine a patient: 45 years old, runs marathons, eats vegan, lean and healthy. They have a massive heart attack on Kelly Drive. The autopsy shows arteries full of plaque despite "normal" cholesterol on every prior panel. In almost every case like this, the cause is Lipoprotein(a).

The I-676 metaphor

If your arteries are the Vine Street Expressway (I-676):

ApoB is the volume of traffic. Too many cars equals traffic jams (plaque).
Lp(a) is not a normal sedan. It is a Mad Max vehicle with spikes on the wheels.

Even if traffic is light (low ApoB), one Lp(a) car can sideswipe the guardrail, crash into other cars, and start a fire. Because of its sticky tail, it does not just drive past. It digs into the artery wall, drags inflammation with it, and slows the body's cleanup crew (the clot-dissolving system).

Why do standard labs miss Lp(a)?

Standard labs miss Lp(a) because for decades it was considered untreatable. About 90% of your Lp(a) level is inherited. If your number is high, it was high when you were born and it will be high when you die. Because it does not drop when you eat salad, traditional medicine ignored it for years. The thinking was: if we cannot fix it with diet or meds, why test it? That logic was wrong. Knowing your Lp(a) changes how we manage every other risk factor.

How do we manage high Lp(a)?

We manage high Lp(a) by lowering the surrounding risk while we wait for new specific drugs to mature. PCSK9 inhibitors like Repatha can lower Lp(a) by about 25 to 30%, and gene-silencing drugs like pelacarsen and olpasiran are in late-stage trials. For now, we focus on aggregate risk. If Lp(a) is a Mad Max car trying to crash, we:

Clear the road: We drive your standard ApoB values down to about 30 to 40 mg/dL with statins, ezetimibe, or PCSK9 inhibitors. PCSK9 inhibitors have the bonus of lowering both ApoB and Lp(a).
Install guardrails: We control blood pressure (target around 120/80) and blood sugar tighter than average to protect the artery wall.
Daily low-dose aspirin (when appropriate): To counter the clotting risk that Lp(a) raises. We discuss bleeding risk first.
Image early: A CT Coronary Angiogram (CTA) with Cleerly AI in your 40s tells us if Lp(a) is already laying down soft plaque, so we can match treatment intensity to the actual disease.

Actionable Steps in Philly

Take the genetic test that changes prevention for life.

Ask for Lp(a) by name at your next blood draw. Cash price is usually about $40.
Treat above 75 nmol/L (or 30 mg/dL) as a real risk signal. Above 125 nmol/L (or 50 mg/dL) is high risk.
Lower ApoB to under 60 mg/dL if your Lp(a) is high.
Cascade test your relatives. Each first-degree relative has a 50% chance of carrying it.

Key Takeaways

Test Once: Levels stay stable for life. You only need to check this once.
Family Risk: If you have it, your siblings and children each have a 50% chance of having it. Cascade screening saves lives.
Aortic Stenosis: High Lp(a) also calcifies the aortic heart valve. We listen carefully for murmurs and order imaging when indicated.

Scientific References

Kronenberg F, et al. "Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement." European Heart Journal. 2022.
Tsimikas S, et al. "Lipoprotein(a) Reduction in Persons with Cardiovascular Disease." New England Journal of Medicine. 2020.
O'Donoghue ML, et al. "Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease." New England Journal of Medicine. 2022.
Reyes-Soffer G, et al. "Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease." Arteriosclerosis, Thrombosis, and Vascular Biology. 2022.

Related Articles:

Dr. Ash is a board-certified internal medicine physician at Fishtown Medicine in Philadelphia. He practices advanced preventive cardiology with a focus on identifying and managing genetic cardiovascular risk early.

Fishtown Medicine | Cardiovascular risk

2418 E York St, Philadelphia, PA 19125(267) 360-7927 hello@fishtownmedicine.comHSA/FSA Eligible

Book Your Diagnostic

Medical Disclaimer: This resource provides clinical context for educational purposes. In the world of Precision Medicine, there is no "one size fits all", the right plan must be matched to your unique lab work, physiology, and goals. Consult Dr. Ash to determine if this approach is right for you, especially if you have chronic health conditions or are taking prescription medications.

Frequently Asked Questions

Common Questions

Deep-Dive Questions

Still have a question?

He answers personally. Usually within a few hours.